2026 Michael J. Rogers: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	81	3812	3513	90	89	254	31402

Research.com Recognitions

2023 - Research.com Biology and Biochemistry in Australia Leader Award

Overview

Michael J. Rogers is affiliated with the Garvan Institute of Medical Research in Australia. Their work is primarily situated in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine, with a particular focus on Molecular Biology among related subfields.

Their research topics cover a range of areas including:

Plant biochemistry and biosynthesis
Bone health and treatments
Bone Metabolism and Diseases
Biomarkers in Disease Mechanisms
Inflammasome and immune disorders
Interferon and immune responses
Adipokines, Inflammation, and Metabolic Diseases

Michael J. Rogers has contributed to several scientific publications. Notable recent papers include:

"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption," published in 2021 in Cell
"Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton," published in 2020 in Bone
"Osteoclasts recycle via osteomorphs during RANKL-stimulated bone resorption," published in 2021 in Cell
"Oxysterols: From physiological tuners to pharmacological opportunities," published in 2020 in British Journal of Pharmacology
"Single cell multi-omics characterise discrete human tendon cells populations that persist in vitro and on fibrous scaffolds," published in 2022 in European Cells and Materials

Their frequent co-authors include:

Séan O'Donoghue
Marcia A. Munoz
Tri Giang Phan
Robert Brink
Oliver P. Skinner

Michael J. Rogers's work has appeared in various publication venues, with recurring contributions to:

Zenodo (CERN European Organization for Nuclear Research)
bioRxiv (Cold Spring Harbor Laboratory)
Cell
Harvard Dataverse
Bone

Best Publications

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

R. G. G. Russell;N. B. Watts;F. H. Ebetino;M. J. Rogers

1897
Citations
Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras

Steven P. Luckman;Steven P. Luckman;David E. Hughes;Fraser P. Coxon;Fraser P. Coxon;R. Graham G. Russell

1509
Citations
Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates

James Edward Dunford;Keith Thompson;Fraser Coxon;S. P. Luckman

1379
Citations
Cellular and molecular mechanisms of action of bisphosphonates

M J Rogers;Sharon Andrea Gordon;H L Benford;Fraser Coxon

1290
Citations
Bisphosphonates: from the laboratory to the clinic and back again.

R.G.G Russell;M.J Rogers

1187
Citations
Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

J. E. Fisher;M. J. Rogers;J. M. Halasy;S. P. Luckman

994
Citations
New insights into the molecular mechanisms of action of bisphosphonates.

Michael John Rogers

858
Citations
Biochemical and molecular mechanisms of action of bisphosphonates

Michael J. Rogers;Julie C. Crockett;Fraser P. Coxon;Jukka Mönkkönen

796
Citations
Molecular mechanisms of action of bisphosphonates: current status.

Anke Jozefien Roelofs;Keith Thompson;Sharon Andrea Gordon;Michael John Rogers

716
Citations
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.

K. L. Kavanagh;K. Guo;James Edward Dunford;James Edward Dunford;James Edward Dunford;X. Wu

661
Citations
Bone remodelling at a glance

Julie C. Crockett;Michael J. Rogers;Fraser P. Coxon;Lynne J. Hocking

613
Citations
Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.

Julie C. Frith;Jukka Mönkkönen;G. Michael Blackburn;R. Graham G. Russell

609
Citations
Molecular mechanisms of action of bisphosphonates.

M.J Rogers;J.C Frith;J.C Frith;S.P Luckman;S.P Luckman;F.P Coxon;F.P Coxon

572
Citations
Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

C M Shipman;Michael John Rogers;J F Apperley;R G Russell

525
Citations
Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.

R. G. G. Russell;Z. Xia;J. E. Dunford;U. Oppermann

518
Citations
Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

Fraser P. Coxon;Miep H. Helfrich;Robert Van't Hof;Saïd Sebti

464
Citations
Further Insight into Mechanism of Action of Clodronate: Inhibition of Mitochondrial ADP/ATP Translocase by a Nonhydrolyzable, Adenine-Containing Metabolite

Petri P. Lehenkari;Maarit Kellinsalmi;Juha P. Näpänkangas;Kari V. Ylitalo

448
Citations
Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL

Cristina Sobacchi;Annalisa Frattini;Matteo M Guerrini;Mario Abinun

447
Citations
Identification of a Novel Phosphonocarboxylate Inhibitor of Rab Geranylgeranyl Transferase That Specifically Prevents Rab Prenylation in Osteoclasts and Macrophages

Fraser P. Coxon;Miep H. Helfrich;Banafshe Larijani;Mariusz Muzylak

418
Citations
Heterocycle‐Containing Bisphosphonates Cause Apoptosis and Inhibit Bone Resorption by Preventing Protein Prenylation: Evidence from Structure‐Activity Relationships in J774 Macrophages

Steven P. Luckman;Steven P. Luckman;Fraser P. Coxon;Fraser P. Coxon;Frank H. Ebetino;R. Graham G. Russell

417
Citations